B-type lymphocytic leukaemia developing seven years after chemoradiotherapy for hodgkin's disease: Report of a case and review of the literature

Arie Ben Yehuda, Eli Okon, Rachel Leizerowttz, Aaron Polliack*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

This report describes the development of B-cell lymphocytic, leukemia, probably a leukaemic phase of non-Hodgkin's lymphoma, in a patient with Hodgkin's disease (HD) who was successfully treated and cured with MOPP combination chemotherapy and mantle radiotherapy. The leukaemia occurred seven years after the completion of chemoradiotherapy, and manifested as peripheral blood and bone-marrow involvement alone without any initial evidence of lymphadenopathy, organomegaly or extranodal disease at the time of diagnosis. The occurrence of B-lymphocytic leukaemia in a cured patient with HD is rare, and the association of these two disorders is reviewed and discussed in the light of current knowledge.

Original languageEnglish
Pages (from-to)265-269
Number of pages5
JournalLeukemia and Lymphoma
Volume1
Issue number3-4
DOIs
StatePublished - 1990
Externally publishedYes

Keywords

  • B cells
  • Chemoradiotherapy
  • Hodgkin's disease
  • Lymphocytic leukaemia
  • Secondary leukaemia

Fingerprint

Dive into the research topics of 'B-type lymphocytic leukaemia developing seven years after chemoradiotherapy for hodgkin's disease: Report of a case and review of the literature'. Together they form a unique fingerprint.

Cite this